Dr. Zhijian Chen, MD

Dr. Chen practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Chen's NPI, 1871720235, was assigned on June 12, 2009. Dr. Chen graduated from Second Military Medical University in 1990. Dr. Chen holds Florida license ME159346.

Dr. Chen's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Chen's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Baptist Health Medical Group Oncology. Dmand AI also links Dr. Chen to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Chen is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Chen's licenses on file in 4 states: Florida, Virginia, North Carolina and Ohio.

CMS data shows 544 Medicare services from Dr. Chen across 6 procedure codes in 2024, for 150 Medicare patients. Medicare paid $38,863 for them.

CMS counts 150 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 66, with 60% women.

In 2024, Dr. Chen wrote 94 Medicare Part D claims for 43 patients. 100% of them were for generic drugs. CMS names the drug for 42 of them, across 2 drugs with 11 or more claims each, at $681 in total drug cost. In 2023, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Dmand AI links 88 papers to Dr. Chen, published from 2003 to 2025. 2009 was the busiest year, with 5. The most frequent topics are Signal Transduction, Immunity, Innate and NF-kappa B. Dr. Chen has published most often in Nature. Dr. Chen's most frequent co-authors are William C. Broaddus, MD, PhD, Sujit S. Prabhu, MD and Brian A. Skaug, MD.

Dmand AI links Dr. Chen to 7 clinical trials, 3 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Glioblastoma, Gliosarcoma and Breast Neoplasms. Virginia Commonwealth University sponsors the most, 3.

CMS Open Payments shows 8 general payments to Dr. Chen from 4 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Foundation Medicine, Inc. paid the most, $229.

Dmand AI lists 2 awards for Dr. Chen, most recently VCU Presidential Research Quest Fund Award in 2019.

Dr. Chen graduated from Second Military Medical University in 1990. Dr. Chen is a member of AAN, ASCO and Society for Neuro-oncology.

Dr. Chen is in network with 14 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.